Quick Answer
Barinthus Biotherapeutics plc. reported Net Income of -$66.43 million for fiscal year 2025.
Barinthus Biotherapeutics plc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$66.43M | -8.8% |
| 2024 | -$61.07M | +16.7% |
| 2023 | -$73.35M | -1473.0% |
| 2022 | $5.34M | +110.5% |
| 2021 | -$50.87M | -187.3% |
| 2020 | -$17.71M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.57M | -79.5% | +31.0% |
| June 30, 2025 | -$21.12M | -24.8% | -7.5% |
| March 31, 2025 | -$19.65M | -26.9% | -142.1% |
| September 30, 2024 | -$8.11M | +42.3% | +52.1% |
| June 30, 2024 | -$16.93M | +28.9% | -9.3% |
| March 31, 2024 | -$15.49M | +14.8% | -10.1% |
| September 30, 2023 | -$14.07M | -270.7% | +40.9% |
| June 30, 2023 | -$23.80M | -251.7% | -30.9% |
- Barinthus Biotherapeutics plc. showed a decrease of -8.8% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Barinthus Biotherapeutics plc.’s net income has declined by 275.2% (from -$17.71 million to -$66.43 million).
- The most recent figure is from Barinthus Biotherapeutics plc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: